CRA analyzed market definition in antitrust litigation concerning a product in the non-opioid pain category. In defining the relevant antitrust market, our work accounted for indicators of competition among branded pharmaceutical products, including market positioning, factors driving physician choice, development of new approved indications, and competition for formulary listing.
The politician and the judge: Implications for competition policy
Drawing on the historical evolution of antitrust policy, the authors argue that some increase in politicisation is likely an inevitable result of the expansion...